95 related articles for article (PubMed ID: 9176754)
1. p53 overexpression and mutation, chemoresistance and patient survival in oral and maxillofacial squamous cell carcinoma.
Cutilli T; Papola F; Corbacelli A
J Chemother; 1997 Apr; 9(2):123-4. PubMed ID: 9176754
[No Abstract] [Full Text] [Related]
2. Evaluation of p53 protein as a prognostic factor for oral cancer surgery.
Cutilli T; Leocata P; Dolo V; Altobelli E
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):922-7. PubMed ID: 23791033
[TBL] [Abstract][Full Text] [Related]
3. [p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].
Cutilli T; Papola F; Di Emidio P; Leocata P; Corbacelli A
Minerva Stomatol; 1998; 47(1-2):1-9. PubMed ID: 9578641
[TBL] [Abstract][Full Text] [Related]
4. p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.
Cutilli T; Papola F; Di Emidio P; Corbacelli A
J Chemother; 1998 Oct; 10(5):411-7. PubMed ID: 9822361
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
[TBL] [Abstract][Full Text] [Related]
6. Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.
Mroz EA; Rocco JW
J Clin Oncol; 2010 Feb; 28(5):715-7. PubMed ID: 20048171
[No Abstract] [Full Text] [Related]
7. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
[TBL] [Abstract][Full Text] [Related]
8. Expression and biological behavior of vascular endothelial growth factor and tumor necrosis factor-α in oral and maxillofacial squamous cell carcinoma.
Xiang W; Xiang P; Wang Y; Chen D
Minerva Chir; 2020 Jun; 75(3):208-209. PubMed ID: 32009336
[No Abstract] [Full Text] [Related]
9. Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma.
Iguchi H; Kusuki M; Nakamura A; Nishiura H; Kanazawa A; Takayama M; Sunami K; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):55-61. PubMed ID: 15513513
[TBL] [Abstract][Full Text] [Related]
10. Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications.
Noguchi M; Kinjyo H; Miyazaki A; Kubota H; Kohama G
Int J Clin Oncol; 2002 Jun; 7(3):138-44. PubMed ID: 12109514
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
12. [Detection of HPV type 16, 18 infection and p53 protein overexpression in oral squamous cell carcinoma].
Minawaer ; Ahmatjan A; Suzuk L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):451-3. PubMed ID: 11930724
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy.
Tatemoto Y; Osaki T; Yoneda K; Yamamoto T; Ueta E; Kimura T
Pathol Res Pract; 1998; 194(12):821-30. PubMed ID: 9894247
[TBL] [Abstract][Full Text] [Related]
14. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
[TBL] [Abstract][Full Text] [Related]
15. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
Fukuda M; Nakatsuka T; Kusama K; Sakashita H
J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
[No Abstract] [Full Text] [Related]
16. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies of preoperative tumor reductive chemotherapy with PPV regimen in the treatment of oral squamous cell carcinoma].
Jin Y; Shen Y; Ma G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 May; 30(3):166-8. PubMed ID: 7489653
[No Abstract] [Full Text] [Related]
18. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).
Laimer K; Blassnig N; Spizzo G; Kloss F; Rasse M; Obrist P; Schäfer G; Perathoner A; Margreiter R; Amberger A
Oral Oncol; 2009 Feb; 45(2):127-34. PubMed ID: 18620895
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
[TBL] [Abstract][Full Text] [Related]
20. [Multidisciplinary treatment of head and neck cancer].
Inuyama Y; Fujii M; Tanaka J; Takaoka T; Hosoda H; Kohno N
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1051-6. PubMed ID: 2414482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
